PART 1: Representations & Warranties Insurance in Today’s Deal Market: Why It Matters More Than Ever
Introduction
Representations and warranties insurance (“RWI”) has rapidly evolved from a niche product used in select transactions to a near-standard feature in middle-market private equity deals. What was once viewed as an optional risk-transfer tool is now often a…
On April 30, 2026, President Trump signed an Executive Order titled “Promoting Efficiency, Accountability, and Performance in Federal Contracting” (the “Order”), directing executive branch agencies to default to fixed-price contracts and contracts that tie contractor profit to performance-based metrics in federal procurement. The Order also requires agencies to review and, to the maximum extent practicable, modify, restructure, or renegotiate their largest non-fixed-price contracts. For context, a companion White House Fact Sheet states that in Fiscal Year 2024, approximately $120 billion was obligated on cost-reimbursement consulting contracts, underscoring the scale of the shift the Order contemplates.
This alert summarizes the key provisions of the Order, analyzes its practical implications for federal contractors and subcontractors, and outlines recommended steps for compliance.
Brightstar Capital Partners has announced an investment in Simon Eye Holdings.
Simon Eye, founded in 1987 and based in Wilmington, Delaware, is an integrated vision care platform providing optometry, optical and ophthalmology services across the Mid-Atlantic region.
Brightstar, founded in 2015 and with headquarters in New York and West Palm Beach, Florida, is…
Stakeholders negotiating sweeping amendments to federal accreditation regulations proposed by the U.S. Department of Education (ED) will begin their final session to achieve consensus on May 18, 2026.
A week-long effort in April revealed deep divisions among negotiators on the Accreditation, Innovation, and Modernization (AIM) Committee of the ED. Debates broke out over the ED’s…
THL Partners has announced the closing of its newest fund.
The fund — THL Equity Fund X — closed with $6.35 billion in investable capital.
THL, founded in 1974 and based in Boston, is a private equity firm investing in middle market growth companies in a few sectors, including healthcare. The firm typically targets…
Mako Capital Group has announced its launch.
Mako, based in Miami, is a private equity firm specializing in acquiring lower-middle market U.S. companies in healthcare, financial and other services. Mako targets businesses with $5 million to $15 million of EBITDA and invests $25 million to $50 million of equity per transaction. The firm was…
Oncology commands roughly 40% of the national drug spend. Retina is close behind. “If you follow the drug spend, you’ll find that the distributors are really building an ecosystem around it,” says Jeanne Proia, managing director at Cross Keys Capital and president of its healthcare services group.
In this conversation with McGuireWoods partner…
THL Partners will acquire Celerion from H.I.G. Capital for $1.8 billion, according to news releases and industry reports.
Celerion, formed in 2010 and based in Lincoln, Nebraska, is a global provider of clinical pharmacology and bioanalytical sciences.
THL, founded in 1974 and based in Boston, is a private equity firm investing in…
On April 30, 2026, the Department of Justice’s (“DOJ”) National Fraud Enforcement Division (“Fraud Division”) announced the formation of the West Coast Health Care Fraud Strike Force, a multi-district enforcement initiative spanning Arizona, Nevada, and the Northern District of California. [1] Announced by Assistant Attorney General Colin McDonald, the new Strike Force signals a significant escalation of federal health care fraud enforcement in the broader West Coast region and warrants close attention from health care providers, technology companies, and other industry participants operating in the area.
The U.S. Department of Health and Human Services Office of Inspector General (OIG) updated its FAQs on Fraud and Abuse Authorities to add a new answer on fair market value (FMV) in FAQ 17 and revise the answer on how the physician self-referral law (Stark Law) overlaps with the federal Anti-Kickback Statute (AKS) in FAQ…
